Literature DB >> 21467629

Lipid metabolism and glial lipoproteins in the central nervous system.

Hideki Hayashi1.   

Abstract

Lipoproteins in the central nervous system (CNS) are not incorporated from the blood but are formed mainly by glial cells within the CNS. In addition, cholesterol in the CNS is synthesized endogenously because the blood-brain barrier segregates the CNS from the peripheral circulation. Apolipoprotein (apo) E is a major apo in the CNS. In normal condition, apo E is secreted from glia, mainly from astrocytes, and forms cholesterol-rich lipoproteins by ATP-binding cassette transporters. Subsequently, apo E-containing glial lipoproteins supply cholesterol and other components to neurons via a receptor-mediated process. Recent findings demonstrated that receptors of the low density lipoprotein (LDL) receptor family not only internalize lipoproteins into the cells but also, like signaling receptors, transduce signals upon binding the ligands. In this review, the regulation of lipid homeostasis will be discussed as well as roles of lipoproteins and functions of receptors of LDL receptor family in the CNS. Furthermore, the relation between lipid metabolism and Alzheimer's disease (AD) is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467629     DOI: 10.1248/bpb.34.453

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  25 in total

1.  Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.

Authors:  Simona Vuletic; Hal Kennedy; John J Albers; Joep Killestein; Hugo Vrenken; Dieter Lütjohann; Charlotte E Teunissen
Journal:  Mult Scler Relat Disord       Date:  2014-07-01       Impact factor: 4.339

Review 2.  MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease.

Authors:  Hyejin Yoon; Luis F Flores; Jungsu Kim
Journal:  Biochim Biophys Acta       Date:  2016-05-04

3.  Dysregulation of Plasmalogen Homeostasis Impairs Cholesterol Biosynthesis.

Authors:  Masanori Honsho; Yuichi Abe; Yukio Fujiki
Journal:  J Biol Chem       Date:  2015-10-13       Impact factor: 5.157

4.  Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.

Authors:  David A Sheridan; S H Bridge; M M E Crossey; D J Felmlee; H C Thomas; R D G Neely; S D Taylor-Robinson; M F Bassendine
Journal:  Metab Brain Dis       Date:  2014-03-12       Impact factor: 3.584

5.  Tissue cholesterol content alterations in streptozotocin-induced diabetic rats.

Authors:  Xin-ting Wang; Jia Li; Li Liu; Nan Hu; Shi Jin; Can Liu; Dan Mei; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2012-06-18       Impact factor: 6.150

6.  Influence of environmental enrichment and depleted uranium on behaviour, cholesterol and acetylcholine in apolipoprotein E-deficient mice.

Authors:  P Lestaevel; F Airault; R Racine; H Bensoussan; B Dhieux; O Delissen; L Manens; J Aigueperse; P Voisin; M Souidi
Journal:  J Mol Neurosci       Date:  2013-06-09       Impact factor: 3.444

Review 7.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

8.  A potential neuroprotective role of apolipoprotein E-containing lipoproteins through low density lipoprotein receptor-related protein 1 in normal tension glaucoma.

Authors:  Hideki Hayashi; Yuko Eguchi; Yuko Fukuchi-Nakaishi; Motohiro Takeya; Naomi Nakagata; Kohichi Tanaka; Jean E Vance; Hidenobu Tanihara
Journal:  J Biol Chem       Date:  2012-06-06       Impact factor: 5.157

9.  Uptake of lipid core nanoparticles by fragments of tissues collected during cerebral tumor excision surgeries: hypotheses for use in drug targeting therapy.

Authors:  Edmundo Luís Rodrigues Pereira; Danielle Cristinne Azevedo Feio; João Pojucan Lobo Tavares; Natalia Megumi Morikawa; Debora Fernandes Deus; Carolina Graziani Vital; Elaine Rufo Tavares; Raul Cavalcante Maranhão
Journal:  J Neurooncol       Date:  2022-05-25       Impact factor: 4.130

10.  Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model.

Authors:  Christine A Curcio; Jeffrey D Messinger; Kenneth R Sloan; Gerald McGwin; Nancy E Medeiros; Richard F Spaide
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.